RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CTT Pharmaceutical Holdings Stock

CTT Pharmaceutical Holdings ROE 2024

CTT Pharmaceutical Holdings ROE

0

Ticker

CTTH

ISIN

US12651E1064

WKN

A14ZP5

In 2024, CTT Pharmaceutical Holdings's return on equity (ROE) was 0, a 0% increase from the 0 ROE in the previous year.

CTT Pharmaceutical Holdings Aktienanalyse

What does CTT Pharmaceutical Holdings do?

CTT Pharmaceutical Holdings Inc. is a leading company in the pharmaceutical industry specializing in the development, manufacturing, and marketing of various cannabis-based products. It was founded in 2007 as a research company focused on the medical applications of cannabis. In 2014, the company received patents for their revolutionary platform technology for delivering cannabinoids through lozenges. CTT's business model is based on the development and commercialization of patented delivery systems for cannabinoids, primarily focusing on lozenges. It has subsidiaries and joint ventures in countries like the US, Mexico, and Australia. CTT aims to be a leading provider of cannabinoid-based medicines, with a focus on pain management, neurological disorders, and cancer treatment. Some of their key products include CannavertTM for chemotherapy-induced nausea and vomiting, OraldissTM for neurological conditions like epilepsy and Parkinson's disease, and AnesthevertTM for acute and chronic pain management. CTT collaborates with other pharmaceutical companies and research institutions to market their products and improve their technology. CTT Pharmaceutical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding CTT Pharmaceutical Holdings's Return on Equity (ROE)

CTT Pharmaceutical Holdings's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing CTT Pharmaceutical Holdings's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

CTT Pharmaceutical Holdings's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in CTT Pharmaceutical Holdings’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about CTT Pharmaceutical Holdings stock

What is the ROE (Return on Equity) of CTT Pharmaceutical Holdings this year?

The ROE of CTT Pharmaceutical Holdings this year is 0 undefined.

How has the Return on Equity (ROE) of CTT Pharmaceutical Holdings developed compared to the previous year?

The ROE of CTT Pharmaceutical Holdings has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of CTT Pharmaceutical Holdings?

A high ROE indicates that CTT Pharmaceutical Holdings generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of CTT Pharmaceutical Holdings?

A low ROE can indicate that CTT Pharmaceutical Holdings is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of CTT Pharmaceutical Holdings affect the company?

A change in ROE (Return on Equity) of CTT Pharmaceutical Holdings can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of CTT Pharmaceutical Holdings?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of CTT Pharmaceutical Holdings?

Some factors that can influence CTT Pharmaceutical Holdings's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does CTT Pharmaceutical Holdings pay?

Over the past 12 months, CTT Pharmaceutical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CTT Pharmaceutical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of CTT Pharmaceutical Holdings?

The current dividend yield of CTT Pharmaceutical Holdings is .

When does CTT Pharmaceutical Holdings pay dividends?

CTT Pharmaceutical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings paid dividends every year for the past 0 years.

What is the dividend of CTT Pharmaceutical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is CTT Pharmaceutical Holdings located?

CTT Pharmaceutical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von CTT Pharmaceutical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CTT Pharmaceutical Holdings from 10/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/27/2024.

When did CTT Pharmaceutical Holdings pay the last dividend?

The last dividend was paid out on 10/27/2024.

What was the dividend of CTT Pharmaceutical Holdings in the year 2023?

In the year 2023, CTT Pharmaceutical Holdings distributed 0 USD as dividends.

In which currency does CTT Pharmaceutical Holdings pay out the dividend?

The dividends of CTT Pharmaceutical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CTT Pharmaceutical Holdings

Our stock analysis for CTT Pharmaceutical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CTT Pharmaceutical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.